When we think about drug discovery, the words fast and efficient don’t usually come to mind - but a Singapore-based biotech startup is challenging that reality.
Nanyang Biologics is harnessing the power of AI and an extensive library of tropical bioactives to accelerate how we discover new treatments, not just for humans, but for animals too.
So how are they doing it?
On the Right Business, Hongbin Jeong speaks to Giang Nyugen, Chief Technology Officer of Nanyang Biologics (NYB), to find out more.

The Agenda: Digital safeguards for our kids during the June holidays
20:37

The Big Story: Why is Singapore being hit by a new US tariff under forced labour concerns?
11:51

What's Trending: Singapore's rat problem is finally under control
19:00